ALFA Finder
Dr. Reddy’s Secures Brazil Approval for Semaglutide Targeting $244.6M Diabetes Market
Dr. Reddy's Laboratories receives ANVISA approval for generic semaglutide in Brazil, targeting a diabetes market estimated at $244.6 million for the injectable.
Approvals
Regulatory approvals, licences and clearances.
Baheti Recycling to Migrate to NSE Main Board Effective November 6, 2026
Baheti Recycling Industries moves 1.04 crore shares from NSE SME Emerge to the Main Board on Nov 6, 2026, following a 36% one-year stock price rally in 2026.
Emmbi Industries Shares Rise 6% in 2 Days Since Regulatory Approval
SEBI grants Emmbi Industries promoters an exemption for a 32.27% share transfer to family trusts. Control remains unchanged as TTM revenue hits ₹481.84 crore.
Bliss GVS Pharma Shares Rise 6% in 4 Days Since Regulatory Approval
Bliss GVS Pharma's UK arm Asterisk Lifesciences receives MHRA marketing authorisation for Mesalazine 1g Suppositories, marking a major regulated market expansion.
Organic Recycling Systems to Consider BSE and NSE Main Board Migration
Organic Recycling Systems Ltd schedules board meeting for Nov 06, 2026, to discuss SME-to-Main-Board migration and a new ESOP scheme for its employees.
Madhusudan Masala Shares Rise 5% in 4 Days Since Sme To Nse Listing
Madhusudan Masala seeks shareholder approval to migrate from NSE Emerge to the Main Boards of NSE and BSE. The company reported a 118.2% YoY revenue growth in Q2.
PCBL Chemical Secures 20-Year Indian Patent for Advanced Carbon Black Composition
PCBL Chemical Ltd secures a 20-year Indian patent for a novel carbon black composition, targeting premium tyre segments. The firm reports ₹2,474 Cr Q2 revenue.
Khazanchi Jewellers Migrates to NSE and BSE Mainboard; Targets ₹5,000 Crore Revenue
Khazanchi Jewellers has migrated to the BSE and NSE Main Board, effective Oct 27, 2026, targeting ₹5,000 crore revenue by FY2030 through retail store expansion.
John Cockerill India Shares Rise 5% in 2 Days Since RBI Approval for Metals International Acquisition
John Cockerill India receives RBI approval to acquire John Cockerill Metals International SA via share swap, supporting its ₹4,598.9 crore consolidated order book.
Gland Pharma Shares Jump 10% in 4 Days Since Regulatory Approval
Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable, bioequivalent to Pfizer's Depo-Medrol, targeting a $214 million annual US market.
City Union Bank Shares Jump 10% in 6 Days Since Regulatory Approval
City Union Bank receives RBI approval to appoint Shri Sankaran G as Executive Director for three years. The bank reported a ₹415.91 crore net profit in Q2 FY27.
Lupin Receives US FDA Approval for Amifampridine Tablets with 180-Day Exclusivity
Lupin receives US FDA approval for Amifampridine Tablets 10 mg. As a first-to-file applicant, the company is eligible for 180-day shared generic exclusivity.
Supreme Infrastructure Shares Skyrocket 39% in 3 Days Since ₹2,200 Crore Debt Settlement
Supreme Infrastructure India Ltd completes a ₹2,200 crore debt settlement under an NCLT-sanctioned scheme, achieving debt-free status for operational revival.
Stonepeak Completes Acquisition of 51% Stake in Castrol India from BP
Castrol India Ltd confirms Stonepeak has acquired indirect control of its 51% promoter stake from BP, representing 50.44 crore shares in the lubricant major.
Veefin Solutions Shares Rise 5% in 2 Days Since NSE Main Board Migration Approval
Veefin Solutions receives NSE in-principle approval to migrate 2.55 crore shares to the Main Board. Company reported Q2 revenue of ₹124.66 Cr and ₹9.02 Cr profit.
Som Distilleries & Breweries Shares Rise 5% in 7 Days Since Regulatory Approval
Som Distilleries & Breweries secures excise licences and label approvals for its Bhopal plant. Manufacturing and sales are set to resume by early November 2026.
Agi Infra Shares Rally 25% in 5 Days Since Regulatory Approval
Agi Infra receives RERA approval for its Utopia by AGI project in New Chandigarh, a high-rise tower valid until 2031, following a ₹27.52 Cr quarterly profit.
360 ONE WAM Shares Soar 20% in 7 Days Since Regulatory Approval
360 ONE WAM subsidiary receives IFSCA approval for brokerage, clearing, and research in GIFT City. The firm manages assets worth over ₹8.99 lakh crore as of 2026.
